Valuation: Boston Scientific Corporation

Market Cap 65.3B 58.59B 54.17B 49.06B 91.65B 6,219B 92.76B 648B 258B 3,255B 245B 240B 10,332B P/E 2026 *
17.5x
P/E 2027 * 17.9x
Enterprise Value 71.71B 64.34B 59.49B 53.87B 101B 6,830B 102B 711B 283B 3,574B 269B 263B 11,346B EV / Sales 2026 *
3.4x
EV / Sales 2027 * 3.2x
Free-Float
82.47%
Yield 2026 *
-
Yield 2027 * -
1 day-4.99%
1 week-6.91%
Current month-2.79%
1 month-3.39%
3 months-6.77%
6 months-29.22%
Current year-55.50%
1 week 39.57
Extreme 39.57
46.16
1 month 39.57
Extreme 39.57
46.16
Current year 39.57
Extreme 39.57
100.9
1 year 39.57
Extreme 39.57
105.65
3 years 39.57
Extreme 39.57
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap. Importance
25/8/26 Buy

Director

2,040 0.0001%
11/8/26 Other

Controller/Auditor

2,930 0.0002%
10/8/26 Other

Chief Financial Officer

9,908 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
-5.84%-6.91%-58.58%-14.32% 65.3B
+1.61%+2.44%+24.90%+63.22% 256B
+0.89%+4.38%+5.91%+24.58% 163B
-0.38%+1.41%-19.42%+71.51% 155B
+1.06%+3.95%+13.56%+48.73% 52.35B
+1.72%+2.78%-13.92%-7.13% 51.93B
+1.39%-0.27%+7.48%+67.70% 50.75B
+2.25%+4.90%+23.80%+76.59% 50.04B
+1.78%+7.69%+35.57%+94.84% 46.03B
+3.33%+7.79%+187.78%+164.41% 42.2B
Average +0.97%+1.99%+20.71%+59.01% 93.26B
Weighted average by Cap. +1.01%+1.80%+12.48%+54.77%

Financials

2026 *2027 *
Net sales 21.07B 18.9B 17.48B 15.83B 29.57B 2,007B 29.93B 209B 83.23B 1,050B 79.06B 77.39B 3,333B 22.14B 19.86B 18.36B 16.63B 31.07B 2,108B 31.44B 220B 87.44B 1,103B 83.07B 81.31B 3,502B
Net income 3.67B 3.29B 3.04B 2.75B 5.14B 349B 5.21B 36.35B 14.48B 183B 13.75B 13.46B 580B 3.68B 3.3B 3.05B 2.76B 5.16B 350B 5.22B 36.45B 14.52B 183B 13.79B 13.5B 582B
Net Debt 6.41B 5.75B 5.32B 4.82B 9B 611B 9.11B 63.58B 25.32B 319B 24.06B 23.55B 1,014B 5.49B 4.93B 4.56B 4.13B 7.71B 523B 7.81B 54.5B 21.71B 274B 20.62B 20.18B 869B
Projected Income Statement - Annual - Boston Scientific Corporation
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
29/10/26 USD 42.43 -5.84% 69,798,000
27/10/26 USD 45.06 -1.14% 15,139,721
26/10/26 USD 45.58 -0.24% 11,928,715
23/10/26 USD 45.69 -0.70% 8,772,772
22/10/26 USD 46.01 +3.37% 16,395,574
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Boston Scientific Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
45.06USD
Average target price
57.34USD
Spread / Average Target
+27.24%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Boston Scientific Corporation